Zaba Valtuille, Eric Acquaviva, Vincent Trebossen, Naim Ouldali, Aurelie Bourmaud, Stéphane Sclison, Alexandre Gomez, Alexis Revet, Hugo Peyre, Richard Delorme, Florentia Kaguelidou
IMPORTANCE: Numerous studies have provided evidence for the negative associations of the COVID-19 pandemic with mental health, but data on the use of psychotropic medication in children and adolescents after the onset of the COVID-19 pandemic are lacking. OBJECTIVE: To assess the rates and trends of psychotropic medication prescribing before and over the 2 years after the onset of the COVID-19 pandemic in children and adolescents in France. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used nationwide interrupted time-series analysis of outpatient drug dispensing data from the IQVIA X-ponent database...
April 1, 2024: JAMA Network Open